Fig. 1.
Frequency of toxicities classified as related to treatment by grade in patients receiving IL-12 and rituximab.
Frequency indicates number of patients; alk phos, alkaline phosphatase; SGOT (AST), aspartate aminotransferase; SGPT, (ALT), alanine aminotransferase.